Analysts rate GMR Solutions Inc. Strong Buy (bullish), based on 8 analysts. Average price target: US$18.63.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
22 of 22 declarations
The 6 sales in the GMR Solutions Inc. record total EUR 24.8 million, with a median of EUR 2,705,751, and no purchase is filed. The three largest were made on the same day, September 14, 2026: Nicola Loporcaro, Chairman & CEO, EUR 15,335,910, Brian Scott Tierney, EVP & CFO, EUR 2,797,466, and Edward Van Horne, President & COO, EUR 2,760,460.
This US healthcare company, listed on Nasdaq and valued at USD 539.1 million, has 22 filings from 12 filers, all filed in 2026 and all within the last twelve months. They include 8 grants, 1 option exercise and 7 other transactions. Brian Scott Tierney signs 4 filings, Thomas A. A. Cook (EVP, GC & Secretary), Lisa Jacoba (EVP & CHRO) and Edward Van Horne 3 each, Nicola Loporcaro 2. Each of these five officers has one sale.
Insiders hold 8% of the capital. Transactions run from December 12, 2025 to September 14, 2026, and the median publication delay is 1 day.
Purchases our model currently ranks for the recommendations list.
All recommendations